A.P. Pharma, Inc.
A.P. Pharma Receives $2.5 Million Milestone Payment
Published in Cancer Law Weekly, January 30th, 2010
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare. The payment represents a milestone payment that recently became payable to the Company under the agreement that the Company entered into on October 1, 2005 to sell its royalty rights to Retin-A Micro® and Carac® to an affiliate of the Paul Royalty Fund.
"We are delighted to receive this non-dilutive funding from Paul Capital Healthcare as we continue to pursue the approval of our first product, APF530, for the prevention of chemotherapy-induced nausea and vomiting in cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2010-01-30)
More Articles from Cancer Law Weekly
- Aasld
AASLD Applauds Landmark IOM Study That Shows the Path to Eradicate Hepatitis B and C - 2Insure4Less.com
2Insure4Less.com's Free Online Comparison Service and iPhone App Help Consumers Start the New Year Right with Strategic Insurance Shopping - 4SC AG
4SC Announces First Patient Treated in a Phase II Hodgkin's Lymphoma Study with HDAC Inhibitor Resminostat 4SC-201 - Abbott
Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test - Acute Lymphoblastic Leukemia
Study results from University of Toronto provide new insights into acute lymphoblastic leukemia in children - Adenocarcinoma
Reports from F. Rivera et al highlight recent research in adenocarcinoma - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
